Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18678878rdf:typepubmed:Citationlld:pubmed
pubmed-article:18678878lifeskim:mentionsumls-concept:C0270611lld:lifeskim
pubmed-article:18678878lifeskim:mentionsumls-concept:C0064219lld:lifeskim
pubmed-article:18678878lifeskim:mentionsumls-concept:C0080093lld:lifeskim
pubmed-article:18678878lifeskim:mentionsumls-concept:C0282625lld:lifeskim
pubmed-article:18678878lifeskim:mentionsumls-concept:C0475224lld:lifeskim
pubmed-article:18678878lifeskim:mentionsumls-concept:C1519726lld:lifeskim
pubmed-article:18678878lifeskim:mentionsumls-concept:C1514758lld:lifeskim
pubmed-article:18678878lifeskim:mentionsumls-concept:C0598958lld:lifeskim
pubmed-article:18678878lifeskim:mentionsumls-concept:C0442797lld:lifeskim
pubmed-article:18678878lifeskim:mentionsumls-concept:C0127400lld:lifeskim
pubmed-article:18678878pubmed:issue43lld:pubmed
pubmed-article:18678878pubmed:dateCreated2008-10-20lld:pubmed
pubmed-article:18678878pubmed:abstractTextPrevious studies indicate that cerebral ischemia breaks the dynamic balance between excitatory and inhibitory inputs. The neural excitotoxicity induced by ionotropic glutamate receptors gain the upper hand during ischemia-reperfusion. In this paper, we investigate whether GluR5 (glutamate receptor 5)-containing kainate receptor activation could lead to a neuroprotective effect against ischemic brain injury and the related mechanism. The results showed that (RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid (ATPA), a selective GluR5 agonist, could suppress Src tyrosine phosphorylation and interactions among N-methyl-D-aspartate (NMDA) receptor subunit 2A (NR2A), postsynaptic density protein 95 (PSD-95), and Src and then decrease NMDA receptor activation through attenuating tyrosine phosphorylation of NR2A and NR2B. More importantly, ATPA had a neuroprotective effect against ischemia-reperfusion-induced neuronal cell death in vivo. However, four separate drugs were found to abolish the effects of ATPA. These were selective GluR5 antagonist NS3763; GluR5 antisense oligodeoxynucleotides; CdCl(2), a broad spectrum blocker of voltage-gated calcium channels; and bicuculline, an antagonist of gamma-aminobutyric acid A (GABA(A)) receptor. GABA(A) receptor agonist muscimol could attenuate Src activation and interactions among NR2A, PSD-95 and Src, resulting the suppression of NMDA receptor tyrosine phosphorylation. Moreover, patch clamp recording proved that the activated GABA(A) receptor could inhibit NMDA receptor-mediated whole-cell currents. Taken together, the results suggest that during ischemia-reperfusion, activated GluR5 may facilitate Ca(2+)-dependent GABA release from interneurons. The released GABA can activate postsynaptic GABA(A) receptors, which then attenuates NMDA receptor tyrosine phosphorylation through inhibiting Src activation and disassembling the signaling module NR2A-PSD-95-Src. The final result of this process is that the pyramidal neurons are rescued from hyperexcitability.lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:languageenglld:pubmed
pubmed-article:18678878pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:citationSubsetIMlld:pubmed
pubmed-article:18678878pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678878pubmed:statusMEDLINElld:pubmed
pubmed-article:18678878pubmed:monthOctlld:pubmed
pubmed-article:18678878pubmed:issn0021-9258lld:pubmed
pubmed-article:18678878pubmed:authorpubmed-author:LiuYongYlld:pubmed
pubmed-article:18678878pubmed:authorpubmed-author:MEOLLlld:pubmed
pubmed-article:18678878pubmed:authorpubmed-author:ZhangGuang-Yi...lld:pubmed
pubmed-article:18678878pubmed:issnTypePrintlld:pubmed
pubmed-article:18678878pubmed:day24lld:pubmed
pubmed-article:18678878pubmed:volume283lld:pubmed
pubmed-article:18678878pubmed:ownerNLMlld:pubmed
pubmed-article:18678878pubmed:authorsCompleteYlld:pubmed
pubmed-article:18678878pubmed:pagination29355-66lld:pubmed
pubmed-article:18678878pubmed:dateRevised2010-9-21lld:pubmed
pubmed-article:18678878pubmed:meshHeadingpubmed-meshheading:18678878...lld:pubmed
pubmed-article:18678878pubmed:meshHeadingpubmed-meshheading:18678878...lld:pubmed
pubmed-article:18678878pubmed:meshHeadingpubmed-meshheading:18678878...lld:pubmed
pubmed-article:18678878pubmed:meshHeadingpubmed-meshheading:18678878...lld:pubmed
pubmed-article:18678878pubmed:meshHeadingpubmed-meshheading:18678878...lld:pubmed
pubmed-article:18678878pubmed:meshHeadingpubmed-meshheading:18678878...lld:pubmed
pubmed-article:18678878pubmed:meshHeadingpubmed-meshheading:18678878...lld:pubmed
pubmed-article:18678878pubmed:meshHeadingpubmed-meshheading:18678878...lld:pubmed
pubmed-article:18678878pubmed:meshHeadingpubmed-meshheading:18678878...lld:pubmed
pubmed-article:18678878pubmed:meshHeadingpubmed-meshheading:18678878...lld:pubmed
pubmed-article:18678878pubmed:meshHeadingpubmed-meshheading:18678878...lld:pubmed
pubmed-article:18678878pubmed:meshHeadingpubmed-meshheading:18678878...lld:pubmed
pubmed-article:18678878pubmed:meshHeadingpubmed-meshheading:18678878...lld:pubmed
pubmed-article:18678878pubmed:meshHeadingpubmed-meshheading:18678878...lld:pubmed
pubmed-article:18678878pubmed:meshHeadingpubmed-meshheading:18678878...lld:pubmed
pubmed-article:18678878pubmed:meshHeadingpubmed-meshheading:18678878...lld:pubmed
More...